QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

FLGT

QT71Fulgent Genetics, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
18.00
+0.30+1.69%
OverviewShort InterestFilings
FLGTQT71Fulgent Genetics, Inc.·NASDAQ
OverviewShort InterestFilings
18.00+1.69%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-2.38
Insider Own-
Shs Outstand-
Perf Week-4.15%
Market Cap502.69MForward P/E-EPS next Y-1.15Insider Trans-Shs Float-Perf Month12.85%
Enterprise Value489.46MPEG0.12EPS next Q-0.46Inst Own-Short Float-Perf Quarter15.68%
Income-67863289.00P/S1.57EPS this Y34.87%Inst Trans-Short Ratio-Perf Half Y-33.73%
Sales320.35MP/B0.52EPS next Y25.81%ROA-6.38%Short Interest-Perf YTD-31.48%
Book/sh-P/C-EPS next 5Y-ROE-6.70%52W High31.04 -42.01%Perf Year-11.15%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-8.96%52W Low13.46 33.73%Perf 3Y-
Dividend Est.-EV/EBITDA-8.36Sales past 3/5Y-19.49% -5.21%Gross Margin38.71%Volatility1.97% 2.83%Perf 5Y-
Dividend TTM-EV/Sales1.53EPS Y/Y TTM100.71%Oper. Margin-33.07%ATR (14)0.71Perf 10Y-
Dividend Ex-Date-Quick Ratio5.31Sales Y/Y TTM13.07%Profit Margin-23.04%RSI (14)52.55Recom2.33
Dividend Gr. 3/5Y-Current Ratio5.31EPS Q/Q-SMA20-1.44%Beta0.72Target Price15.00
Payout0.00%Debt/Eq0.01Sales Q/Q-2.74%SMA507.91%Rel Volume1.34Prev Close17.70
Employees1,313LT Debt/Eq0.01EarningsJul 31SMA200-17.10%Avg Volume511.18KPrice18.00
IPO DateSep 29, 2016Option/ShortYes / YesEPS/Sales Surpr.-3.40% 4.41%Net Debt/EBITDA0.23Volume684,420Change1.69%
Analyst Ratings
DateActionAnalystRatingTarget
May-05-26ReiteratedPiper SandlerNeutral$21 → $15
Nov-14-25ReiteratedRaymond JamesOutperform$25 → $36
Aug-05-25UpgradeUBSNeutral → Buy$30
Aug-04-25ReiteratedPiper SandlerNeutral$40 → $21
May-05-25ReiteratedRaymond JamesOutperform$45 → $25
Dec-08-22DowngradePiper SandlerOverweight → Neutral$70 → $40
Nov-18-22ReiteratedRaymond JamesOutperform$45
Nov-14-22ReiteratedCredit SuisseOutperform$50
Jan-08-21DowngradeCredit SuisseNeutral → Underperform
Nov-24-20DowngradeBTIGBuy → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue320323283
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A197192176
Gross Profit124131107
Selling, General and Administrative Excl. Other167160124
Research and Development555449
Other Operating Expense888
Operating Income-106-91-74
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)-23-21-22
Net Income Before Taxes-83-70-52
Income Taxes-8-8-8
Consolidated Net Income-74-61-43
Net Income From Continuing Operations-75-62-44
Net Income-74-61-43
EPS (Recurring)-2.38-1.97-1.41
EPS (Basic, Before Extraordinaries)-2.38-1.97-1.41
EPS (Diluted)-2.38-1.97-1.41
EBITDA-58-46-27
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.742.52—
Gross Margin38.7540.5637.81
Operating Margin-33.13-28.17-26.15
Net Margin-23.13-18.89-15.19
Shares Outstanding313130
Market Capitalization558814—
Operating Lease Expense
———
Insider Trading Volume
$19.31$17.56$15.81$14.07$12.32● Close Price0.00K97.84K195.67K293.51K391.35KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Xie JianPresident and COOMay 27 '26Sale17.601,20121,138369,751May 28 12:00 AM
Gao HanlinChief Scientific OfficerMay 27 '26Sale17.6094516,632992,062May 28 12:00 AM
Gao HanlinChief Scientific OfficerDec 02 '25Sale28.331,07530,457952,890Dec 03 12:00 AM
Xie JianPresident and COODec 02 '25Sale28.331,14032,298336,749Dec 03 12:00 AM
Xie JianPresident and COONov 28 '25Sale29.571,19835,424337,889Dec 01 12:00 AM
Gao HanlinChief Scientific OfficerNov 28 '25Sale29.5794327,884953,965Dec 01 12:00 AM
Xie JianPresident and COONov 24 '25Sale30.4768120,752339,087Nov 25 12:00 AM
Gao HanlinChief Scientific OfficerNov 24 '25Sale30.4753516,303954,908Nov 25 12:00 AM
Xie JianPresident and COONov 19 '25Sale29.1010,000290,983349,768Nov 21 12:00 AM
Xie JianPresident and COOSep 03 '25Sale22.031,12824,846364,121Sep 03 12:00 AM
Gao HanlinChief Scientific OfficerSep 03 '25Sale22.031,06323,414957,085Sep 03 12:00 AM
Gao HanlinChief Scientific OfficerAug 27 '25Sale21.4894320,260958,148Aug 28 12:00 AM
Xie JianPresident and COOAug 27 '25Sale21.481,19925,760365,249Aug 28 12:00 AM
Xie JianPresident and COOAug 25 '25Sale21.5069614,965366,448Aug 26 12:00 AM
Gao HanlinChief Scientific OfficerAug 25 '25Sale21.5054811,783959,091Aug 26 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR